Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Hypertension linked to PDE3A activation

Nature Genetics volume 47, pages 562–563 (2015)Cite this article

Subjects

A new study identifies PDE3A mutations as the cause of brachydactyly type E with hypertension. These mutations alter PDE3A activity by uncovering cryptic sites for phosphorylation by PKA and PKC, leading to enzyme hyperactivation that abnormally lowers cAMP levels.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: HTNB-associated mutations alter PDE3A activity.

References

  1. Maass, P.G. et al. Nat. Genet. 47, 647–653 (2015).

    Article  CAS  Google Scholar 

  2. Lugnier, C. Pharmacol. Ther. 109, 366–398 (2006).

    Article  CAS  Google Scholar 

  3. Francis, S.H. & Corbin, J.D. Expert Opin. Drug Metab. Toxicol. 1, 283–293 (2005).

    Article  CAS  Google Scholar 

  4. Schafer, P.H. et al. Br. J. Pharmacol. 159, 842–855 (2010).

    Article  CAS  Google Scholar 

  5. Morales Vidal, S.G. & Ruland, S. Neurol. Clin. 31, 633–657 (2013).

    Article  Google Scholar 

  6. Houslay, M.D. Trends Biochem. Sci. 35, 91–100 (2010).

    Article  CAS  Google Scholar 

  7. Vandeput, F. et al. Proc. Natl. Acad. Sci. USA 110, 19778–19783 (2013).

    Article  CAS  Google Scholar 

  8. Burgin, A.B. et al. Nat. Biotechnol. 28, 63–70 (2010).

    Article  CAS  Google Scholar 

  9. McPhee, I. et al. J. Biol. Chem. 274, 11796–11810 (1999).

    Article  CAS  Google Scholar 

  10. Cedervall, P. et al. Proc. Natl. Acad. Sci. USA 112, E1414–E1422 (2015).

    CAS  PubMed  Google Scholar 

  11. Bolger, G.B. et al. Cell. Signal. 27, 756–769 (2015).

    Article  CAS  Google Scholar 

  12. Han, S.J. et al. EMBO J. 25, 5716–5725 (2006).

    Article  CAS  Google Scholar 

  13. Yan, Y. et al. J. Neurol. Sci. 338, 3–11 (2014).

    Article  CAS  Google Scholar 

  14. Kaname, T. et al. Cell. Signal. 26, 2446–2459 (2014).

    Article  CAS  Google Scholar 

  15. Abbott-Banner, K.H. & Page, C.P. Basic Clin. Pharmacol. Toxicol. 114, 365–376 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Miles Houslay is at the Institute of Pharmaceutical Science, King's College London, London, UK, and Mironid, Ltd., BioCity Scotland, Newhouse, UK.,

    Miles Houslay

Authors
  1. Miles Houslay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miles Houslay.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Houslay, M. Hypertension linked to PDE3A activation. Nat Genet 47, 562–563 (2015). https://doi.org/10.1038/ng.3316

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.3316

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing